三友醫療(688085.SH)2021年度淨利潤預增48.45%-60.26%
格隆匯1月19日丨三友醫療(688085.SH)公佈,預計2021年度實現營業收入5.8億元到6.15億元,與上年同期相比,將增加1.90億元到2.25億元,同比增長48.55%到57.52%。
預計2021年度實現歸屬於母公司所有者的淨利潤1.76億元到1.9億元,與上年同期相比,將增加5744萬元到7144萬元,同比增長48.45%到60.26%。
預計2021年度實現歸屬於母公司所有者的扣除非經常性損益的淨利潤1.24億元到1.35億元,與上年同期相比,將增加2938萬元到4038萬元,同比增長31.05%到42.67%。
主要原因為:2020年第一季度和第二季度前期受疫情擴散、醫院停診及企業延期復工的影響,公司的產品銷售受到了比較大的影響。2021年雖然疫情仍時有反覆,但與去年相比,除個別疫情較為嚴重的城市外,大部分地區的疫情已得到較為有效的控制,醫院骨科手術有序進行。同時公司繼續加強市場開拓和渠道建設,積極有效地進行創新產品推廣和培訓,推進渠道進一步下沉,實現公司產品銷售穩步增長。
公司2020年度非經常性損益金額為2393.81萬元,預計2021年度非經常性損益對淨利潤的影響金額為4500萬元到6500萬元之間,主要系公司持有的金融資產公允價值變動收益、政府補助及理財收益。
公司控股子公司北京水木天蓬醫療技術有限公司於2021年7月起納入公司合併報表範圍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.